Spectral posts investor presentation after FDA De Novo clearance
Spectral AI said its investor presentation highlights FDA De Novo clearance, BARDA funding and near-term commercial launch plans.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.